Browse articles from EyeWorld.org related to LASIK. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
➤ First patients dosed in Phase 3 program evaluating sustained drug delivery for DME ➤ FDA accepts supplemental NDA for presbyopia treatment ➤ FDA grants IND to ocular inflammation, pain treatment for potential expanded indication ➤ Enrollment complete in Phase 3 trial evaluating retinitis pigmentosa therapy ➤ ASCRS news and events
➤ Positive results in Phase 3 superiority trial for wet AMD treatment ➤ Dosing begins for first-in-human myopia prevention drop ➤ Pre-NDA meeting with FDA for IOP-lowering drop ➤ Company news ➤ ASCRS news and events
➤ Study: ‘revolutionary,’ ‘world-first’ treatment for vision-threatening condition restores sight ➤ IDE granted to tissue-based presbyopia solution ➤ Fast Track designation granted for geographic atrophy treatment ➤ Phase 1 results for Stargardt gene therapy ➤ Topline Phase 1b results from study comparing a next-gen treatment to faricimab ➤ Enrolled patients complete dosing in part of trial evaluating X-linked retinoschisis therapy ➤ Company news ➤ ASCRS news and events
➤ Updates on trial and patient experience with artificial cornea ➤ Positive clinical trial update for Usher syndrome type 1B ➤ Positive topline data from Phase 2 study investigating DME and nAMD treatment ➤ First patient dosed in second Phase 3 trial evaluating drop for night vision disturbances ➤ Partnership and company news ➤ ASCRS news and events
➤ Preservative-free fixed-dose combination therapy for glaucoma in development ➤ Rare Pediatric Disease designation granted to investigational Stargardt gene therapy ➤ First patient dosed in genome editing program for corneal dystrophy ➤ ASCRS news and events
Patients who opt for an advanced-technology IOL tend to have higher expectations for their postop vision, and as such, most surgeons proficient with these lenses are prepared to provide enhancements. So while some level of enhancements are expected, what is an “acceptable” rate? Two surgeons discussed the topic.
LASIK volumes in the U.S. have declined in the last year, but this isn’t necessarily a bad thing, according to several EyeWorld Editorial Board members who commented on their recent observations with LASIK volumes compared to refractive surgery volume as a whole.
In her introduction, Karolinne Rocha, MD, PhD, previewed the articles in the Refractive section and specifically shared some thoughts on the trends that may be causing a decline in LASIK procedures.
➤ FDA grants 510(k) indication expansion for MIGS tool ➤ FDA approves biosimilar for aflibercept ➤ De Novo Marketing Authorization granted for home OCT device ➤ Consensus guidelines for suprachoroidal drug delivery ➤ ASCRS news and events
➤ World’s first whole-eye transplant ➤ Regenerative Medicine Advanced Therapy designation for investigational therapy for Leber congenital amaurosis ➤ 48-month trial data for retinal prosthesis for patients with severe atrophic AMD ➤ First patient dosed in Phase 1/2 trial for Stargardt disease gene therapy ➤ Partnership to develop molecule targeting DME ➤ ASCRS news and events